Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsVimta labs

    Vimta Labs

    Jump to

    • Vimta Labs Standalone September 2025 Net Sales at Rs 101.85 crore, up 22.5% Y-o-Y

    • Promoter sells 0.66% stake in Aarti Pharmalabs; Norges Bank, Vanguard Group pick 1.7% shares for Rs 145.8 crore

      Aarti Pharmalabs shares rallied 3.3 percent to Rs 930.2 amid significant volumes on the NSE.

    • Trade Spotlight: How should you trade Star Cement, Fortis Healthcare, Vimta Labs, Hitachi Energy, Metropolis Healthcare and others on August 4?

      While the market may rebound following last week’s sell-off, the key factor to watch is sustainability. Below are some short-term trading ideas to consider.

    • Trade Spotlight: How should you trade Eternal, Cipla, Shyam Metalics, Torrent Pharma, Hubtown, Vimta Labs and others on July 28?

      The market is expected to consolidate further as long as the frontline indices continue trading below their medium-term moving averages. Below are some short-term trading ideas to consider.

    • Vimta Labs Standalone June 2025 Net Sales at Rs 9.76 crore, down 87.83% Y-o-Y

    • Vimta Labs Consolidated December 2024 Net Sales at Rs 89.92 crore, up 10.09% Y-o-Y

    • Vimta Labs Standalone December 2024 Net Sales at Rs 88.52 crore, up 10.51% Y-o-Y

    • Stock Radar: Indus Towers, PG Electroplast, Bharat Forge, Indraprastha Gas, Torrent Pharma, Dynamic Services in focus on Thursday

      Stocks like Larsen & Toubro, Mastek, Bondada Engineering, Gallantt Ispat, Force Motors, Hero MotoCorp, Mazagon Dock Shipbuilders, Suraj Estate Developers, HT Media, Technopack Polymers, Vimta Labs, and Muthoot Microfin will also be in focus on December 5.

    • Vimta Labs Standalone September 2024 Net Sales at Rs 83.14 crore, up 15.06% Y-o-Y

    • Vimta Labs Consolidated September 2024 Net Sales at Rs 84.74 crore, up 15.44% Y-o-Y

    • Vimta Labs Consolidated June 2024 Net Sales at Rs 81.76 crore, down 2.07% Y-o-Y

    • Vimta Labs Standalone June 2024 Net Sales at Rs 80.20 crore, down 2.43% Y-o-Y

    • Vimta Labs Standalone March 2024 Net Sales at Rs 78.34 crore, down 3.05% Y-o-Y

    • Vimta Labs Consolidated March 2024 Net Sales at Rs 79.69 crore, down 2.61% Y-o-Y

    • Vimta Labs Consolidated December 2023 Net Sales at Rs 81.68 crore, up 5.55% Y-o-Y

    • Vimta Labs Standalone December 2023 Net Sales at Rs 80.10 crore, up 4.71% Y-o-Y

    • Vimta Labs Consolidated September 2023 Net Sales at Rs 73.41 crore, down 8.07% Y-o-Y

    • Vimta Labs Standalone September 2023 Net Sales at Rs 72.26 crore, down 8.68% Y-o-Y

    • Vimta Labs Consolidated June 2023 Net Sales at Rs 83.49 crore, up 5.5% Y-o-Y

    • Vimta Labs Standalone June 2023 Net Sales at Rs 82.19 crore, up 4.46% Y-o-Y

    • Vimta Labs Consolidated March 2023 Net Sales at Rs 81.82 crore, up 10.44% Y-o-Y

    • Vimta Labs Standalone March 2023 Net Sales at Rs 80.80 crore, up 9.79% Y-o-Y

    • Vimta Labs Consolidated December 2022 Net Sales at Rs 77.38 crore, up 14.92% Y-o-Y

    • Vimta Labs Standalone December 2022 Net Sales at Rs 76.50 crore, up 14.72% Y-o-Y

    • Vimta Labs Consolidated September 2022 Net Sales at Rs 79.85 crore, up 5.77% Y-o-Y

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347